Status:
COMPLETED
Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The ARDS has a clinical definition with criteria of the American-European Consensus Conference (1994). This definition inconveniently applies to a lot of patients with acute respiratory failure. We k...
Detailed Description
This multicentric prospective observational study will compare the level of different biomarkers specific to ARDS damages : the soluble form of the receptor for advanced glycation end products (sRAGE)...
Eligibility Criteria
Inclusion
- Patients \> 18 years
- Patients within the first 24 hours after onset of ARDS according to the 1994 American-European Consensus Conference (AECC)
- Patients under mechanical ventilation
Exclusion
- Pregnancy
- Acute exacerbation of diabetes
- Dialysis for end-stage kidney disease
- Alzheimer's disease
- Amyloidosis
- Evolutive neoplastic lesion
- Chronic hepatic disease: type C hepatitis, non alcoholic cirrhosis and adenocarcinoma.
- Evolutive COPD
- Patients enrolled in another study
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT01161901
Start Date
June 1 2010
End Date
November 1 2011
Last Update
July 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003